CannaTech Announces 3 Summit

CannaTech Announces 3 Summit

CannaTech 3th edition in Tel Aviv, an unprecedented global event in the medical cannabis industry

CannaTech will showcase the latest science, data trends in the medical cannabis industry, showcasing new technologies, Research & Development. So the innovations that will guide the future of this multi-billion dollar industry. Today CannaTech is therefore announcing its 3rd annual summit. This will take place in Tel Aviv, Israel, from March 20 to 22, 2017.


CannaTech 3 Edition

Presentations will be given by international industry leaders from many disciplines. In addition, we will find science, research, finance, agro-tech, government policy etc. Tickets are on sale until December 18 and cost the modest sum of $ 420 for 2 days of the event… CannaTech also offers a separate fee for a third exclusively VIP day (including a hiking trip).

to read :  Epidiolex, to treat epilepsy, the first FDA-approved cannabis drug

Renowned speakers

Confirmed, renowned speakers such as Professor of Pharmacology, Psychiatry and Behavioral Sciences, Dr. Nephi Stella of the University of Washington. Whose neuroscience research laboratory deals exclusively with cannabis.

Cristina Sanchez, Molecular Biologist at Compultense

Cristina Sanchez, Ph.D., molecular biologist at the University of Compultense in Madrid (Spain), which conducts innovative research into the role of cannabis in the treatment of cancer.

They will be joined by many of Israel's industry leaders among them, the Dr. David Meriri, a leading cannabis researcher at Technion, whose laboratory is currently studying the therapeutic potential of cannabinoids against all kinds of tumors.

Last year CannaTech predicted the market explosion and the de-criminalization of medical cannabis

Mr. Saul Kaye'sI can, CEO of Israel-cannabis, will feature several of its international speakers such as Dr Mowgli Ph.D. Holmes and Nishan Karassik the co-founder and CEO of Phylos BioScience, and Jody Simon, of CommGeniX.

Kalytera Therapeutics are the proud sponsors of the CannaTech 2017. Thus, Kalytera advances a portfolio to fund research on the non-psychoactive cannabinoid (s) (CBD). Will be concerned endocannabinoids usable as drugs. Dr. Raphael Mechoulam, the most influential cannabis medicine researcher so far was the former CannaTech speaker, and co-chair of their scientific team.

FireShot-capture-104-2017 cannatech-___-https www-cannatech-co_
Saul Kaye and the prestigious Dr. Raphael Mechoulam,

“CannaTech is a global ecosystem that allows participants to meet and collaborate with the upper echelon of this industry. Most of the other lectures focus on what's going on in cannabis now. CannaTech is the place to see what's in store for the future of cannabis, ”said Saul Kaye, CEO of iCAN

Tags : BusinessbiotechnologyCareersIsraelMedical

The author Weed-master

Weed media broadcaster and communications manager specializing in legal cannabis. Do you know what they say? knowledge is power. Understand the science behind cannabis medicine, while staying up to date with the latest health related research, treatments and products. Stay up to date with the latest news and ideas on legalization, laws, political movements. Discover tips, tricks and how-to guides from the most seasoned growers on the planet as well as the latest research and findings from the scientific community on the medical qualities of cannabis.